YIDU TECH (02158) has bought back nearly 3.2 million shares four times in half a month, costing approximately 18.6 million Hong Kong dollars.
Medical Journey Technology announced that since September 26, the company has conducted a total of 4 buybacks, repurchasing a total of 3.1916 million shares with a total repurchase amount of 18.6359 million Hong Kong dollars.
YIDU TECH (02158) announced that on October 14, it repurchased 147.28 million shares at a price of HK $5.75-5.99 per share, with a total repurchase amount of HK $8.58 million. Since September 26, the company has conducted a total of 4 repurchases, repurchasing a total of 3.19 million shares, with a cumulative repurchase amount of HK $18.64 million.
In recent news, the world's first topical treatment gel for superficial infantile hemangiomas in the proliferative phase - malysilol gel has been approved for listing. YIDU TECH provides key market research and project research analysis services, which have provided important support for the development and listing of drugs.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
